Efficacy and safety of the subcutaneous implantable cardioverter defibrillator in patients with and without obesity: An international, bicentric retrospective registry
Despite higher shock impedance during DFT at S-ICD implantation, shock efficacy remained stable during implantation and follow-up in both groups. Fewer infectious but more system-specific complications may manifest in patients with obesity compared to non-obese patients.
Authors
- David M. Leistner (ORCID: https://orcid.org/0000-0002-4351-420X)
- Tamás Szili‐Török (ORCID: https://orcid.org/0000-0001-8675-9234)
- Reza Wakili (ORCID: https://orcid.org/0000-0002-6326-1537)
- Anna Vágvölgyi (ORCID: https://orcid.org/0000-0002-8810-700X)
- Florian Hecker
- M Miklos
- Julia W. Erath (ORCID: https://orcid.org/0000-0003-3145-6767)
- Jana Kupusović (ORCID: https://orcid.org/0000-0002-7661-4565)
- Christian Gold (ORCID: https://orcid.org/0000-0002-8654-7474)
- Máté Vámos (ORCID: https://orcid.org/0000-0003-1611-4443)
- Flóra Diána Gausz (ORCID: https://orcid.org/0000-0002-4058-7710)
Institutions
- Goethe University Frankfurt (DE)
- University of Szeged (HU)
- University Hospital Frankfurt (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1007/s00392-025-02834-x
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00